Cargando…

Targeted drugs for pulmonary arterial hypertension: a network meta-analysis of 32 randomized clinical trials

BACKGROUND: Pulmonary arterial hypertension (PAH) is a devastating disease and ultimately leads to right heart failure and premature death. A total of four classical targeted drugs, prostanoids, endothelin receptor antagonists (ERAs), phosphodiesterase 5 inhibitors (PDE-5Is), and soluble guanylate c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Xiao-Fei, Zhang, Jun-Jie, Jiang, Xiao-Min, Ge, Zhen, Wang, Zhi-Mei, Li, Bing, Mao, Wen-Xing, Chen, Shao-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428768/ https://www.ncbi.nlm.nih.gov/pubmed/28507431 http://dx.doi.org/10.2147/PPA.S133288

Ejemplares similares

Meta-Analysis of Pulmonary Artery Denervation for Treatment of Pulmonary Hypertension
por: Zuo, Wanyun, et al.
Publicado: (2022)

Efficacy and safety of oral targeted therapies in pulmonary arterial hypertension: a meta-analysis of randomized clinical trials
por: Zheng, Ya-guo, et al.
Publicado: (2018)

Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
por: Di Benedetto, Paola, et al.
Publicado: (2020)

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2009)

Role of macrophages in pulmonary arterial hypertension
por: Zhang, Meng-Qi, et al.
Publicado: (2023)

Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening
por: Liu, Shao-Fei, et al.
Publicado: (2022)

The relationship between endothelial progenitor cells and pulmonary arterial hypertension in children with congenital heart disease
por: Sun, Hong-Xiao, et al.
Publicado: (2019)

Meta-analysis of randomized controlled trials of bosentan for treatment of pulmonary arterial hypertension
por: Lee, Young Ho, et al.
Publicado: (2013)

New Drugs and Therapies in Pulmonary Arterial Hypertension
por: Shah, Aangi J., et al.
Publicado: (2023)

Diagnostic value of computed tomography‐based pulmonary artery to aorta ratio measurement in chronic obstructive pulmonary disease with pulmonary hypertension: A systematic review and meta‐analysis
por: Wu, Xing‐gui, et al.
Publicado: (2022)

The safety of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension: Protocol for a systemic review and network meta-analysis
por: Gu, Zhi-Chun, et al.
Publicado: (2018)

Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs
por: Jin, Qi, et al.
Publicado: (2023)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
por: Tan, Rubin, et al.
Publicado: (2022)

Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension
por: Wu, Sheryl, et al.
Publicado: (2022)

Sotatercept for the treatment of pulmonary arterial hypertension: a meta-analysis of randomized controlled trials
por: Jaiswal, Vikash, et al.
Publicado: (2023)

Survival benefits of oral anticoagulants in patients with pulmonary arterial hypertension: Protocol for a systematic review and meta-analysis
por: Zhang, Hai-Chao, et al.
Publicado: (2018)

Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis
por: Fu, Wenhai, et al.
Publicado: (2021)

Management of pregnant patients with pulmonary arterial hypertension
por: Zhang, Xiao, et al.
Publicado: (2022)

Microarray profiling of long noncoding RNAs associated with idiopathic pulmonary arterial hypertension
por: Han, Bing, et al.
Publicado: (2019)

CBLN2 rs2217560 was Associated with Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus
por: Huang, Can, et al.
Publicado: (2018)

Pharmacokinetics of treprostinil in children with functional single-ventricle pulmonary arterial hypertension: a randomized controlled trial
por: Chen, Xi, et al.
Publicado: (2021)

Drug repositioning in pulmonary arterial hypertension: challenges and opportunities
por: Grinnan, Daniel, et al.
Publicado: (2019)

Differential expression of microRNA in the lungs of rats with pulmonary arterial hypertension
por: Xiao, Tingting, et al.
Publicado: (2017)

Microarray profiling of long non-coding RNAs associated with idiopathic pulmonary arterial hypertension
por: Han, Bing, et al.
Publicado: (2017)

Impact of right ventricular dyssynchrony on prognosis of patients with idiopathic pulmonary arterial hypertension
por: Cheng, Xiao-Ling, et al.
Publicado: (2019)

Antithrombotic Regimens for Patients Taking Oral Anticoagulation After Coronary Intervention: A Meta‐analysis of 16 Clinical Trials and 9185 Patients
por: Gao, Xiao‐Fei, et al.
Publicado: (2015)

Effects of oral targeted treatments in pulmonary arterial hypertension: A systematic review and meta-analysis
por: Zhu, Hui-ru, et al.
Publicado: (2022)

Text Mining-Based Drug Discovery for Connective Tissue Disease–Associated Pulmonary Arterial Hypertension
por: Tan, Jiang-Shan, et al.
Publicado: (2022)

A Bayesian network meta-analysis on the efficacy and safety of eighteen targeted drugs or drug combinations for pulmonary arterial hypertension
por: Wang, Sumei, et al.
Publicado: (2018)

The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension
por: Zeng, Wei-Jie, et al.
Publicado: (2012)

Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension
por: Alencar, Allan K. N., et al.
Publicado: (2017)

Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension
por: Nakamura, Kazufumi, et al.
Publicado: (2017)

Network module‐based drug repositioning for pulmonary arterial hypertension
por: Wang, Rui‐Sheng, et al.
Publicado: (2021)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Pulmonary Arterial Hypertension
por: Michelakis, Evangelos D., et al.
Publicado: (2007)

Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system
por: Liu, Chen, et al.
Publicado: (2016)

Gender differences in pulmonary arterial hypertension patients with BMPR2 mutation: a meta-analysis
por: Ge, Xiaoyue, et al.
Publicado: (2020)

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension
por: Chen, Yong-Jie, et al.
Publicado: (2021)

Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension
por: Yu, Zhijie, et al.
Publicado: (2022)

Role of Gut Microbiota in Pulmonary Arterial Hypertension
por: Wu, Panyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v5vel9q7dc5vnt7q03m040530g